Flow cytometry-based analysis of tumor-infiltrating immune cells and their characteristics. Assesses immune microenvironment composition to predict immunotherapy response.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangzhou LBP Medicine Science & Technology Co.,Ltd.
China · 1 relevant product
axiVEND microarrays
United States · 1 relevant product
Cambrian Bioworks LLC
United States · 1 relevant product
PreceDo Pharmaceuticals Co.Ltd.
China · 1 relevant product
Promega Corporation
United States · 2 relevant products
Qingdao Raisecare Biological Technology Co., Ltd.
China · 3 relevant products
Qassay
United States · 3 relevant products
guangzhou biotron technolongy co.,ltd
China · 3 relevant products
Mikrogen GmbH
Germany · 1 relevant product
Wiener lab.
Brazil · 1 relevant product
31 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 50 closest product alternatives
Guangzhou LBP Medicine Science & Technology Co.,Ltd. · China
Comprehensive tumor profiling panel utilizing LBP, IHC, PCR, and FISH methods to characterize tumor biology. This integrated approach provides multi-level diagnostic information for precision oncology.
axiVEND microarrays · United States
Specialized multiplex microarray systems for simultaneous measurement of multiple cytokines in biological samples. Supports immunological research and inflammatory biomarker analysis.
Cambrian Bioworks LLC · United States
Integrated automated solution for comprehensive cancer genomics profiling. Processes tissue and blood samples for precision oncology diagnostics and treatment planning.
PreceDo Pharmaceuticals Co.Ltd. · China
A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
Promega Corporation · United States
Functional cell-based reporter bioassay designed to measure activity of biologics targeting immune checkpoint receptors. Supports characterization and potency testing of immunotherapy drug candidates.
Qingdao Raisecare Biological Technology Co., Ltd. · China
Advanced diagnostic test for measuring and analyzing immunological biomarkers in patient samples. Supports precise immune assessment to enable targeted therapeutic pathways and improved clinical outcomes.
Qingdao Raisecare Biological Technology Co., Ltd. · China
Laboratory testing system for evaluating immune function parameters and immunological status. Provides quantitative assessment of immune response markers to guide clinical decision-making in diagnosis and treatment planning.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Mikrogen GmbH · Germany
Advanced T-cell diagnostic assays that enable precise analysis of T-cell function and activity for developing tailored therapies for various diseases. These tests utilize proprietary, patented technologies to achieve pathogen-specific stimulation of cell-mediated immune response and subsequent identification of secreted biomarkers. The assays are designed to support personalized medicine approaches by interrogating the immune system.
Wiener lab. · Brazil
Immunoassay tests for detecting cancer-associated markers in blood samples. These tests provide diagnostic and prognostic information for oncology patients.
Promega Corporation · United States
Cell-based bioluminescent reporter assays for quantifying cytokine immunotherapy targets. Enables functional bioassay screening and characterization during antibody and biologic drug development.
38 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products